Direct photodynamic therapy for vulnerable plaque: Investigation of light dosimetry for depth control

S. Ohmori, T. Yanagihara, Tsunenori Arai

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Photodynamic therapy (PDT) mechanism with high-intensity pulsed laser excitation has not been well understood. We think complete understanding of this unknown effect in PDT leads perfect treated depth control at various lesions. To realize the depth controlled PDT for atheromatous plaque therapy with a fibrous cap intact and surrounding damage free, we studied PDT against murine macrophage-like cells in vitro with the second-generation chlorin photosensitizer manufactured by Photochemical Co. Ltd. (Okayama Japan). The relation between the excitation conditions (pulse energy density and repetition rate) and PDT photocytotoxicity was examined in vitro. The XeCl excimer laser pumped dye laser (wavelength: 669±3 nm, pulse duration: 7ns in FWHM) was used with the pulse energy density from 1.2 to 9.5 mJ/cm2, and the pulse repetition rate from 5 to 80 Hz. Under higher pulse energy density condition, no significant PDT photocytotoxicity was obtained. We examined the photobleaching of the protein containing photosensitizer medium solution, which is considered to correlates with the generation of singlet oxygen. Under higher pulse energy condition, the photobleaching efficiency decrease was observed and the measured PDT effect decrease in terms of laser pulse energy density could be explained by the photobleaching. We measured the oxygen partial pressure in photosensitizer medium solution immediately after the laser exposure. The decrease of oxygen partial pressure, i.e., the amount of the oxygen consumption during the laser exposure was observed 46 mmHg under the excitation condition of the pulse energy density of 9.5 mJ/cm2, the total fluence of 5 J/cm2, the repetition rate of 80Hz, and correlated with the bleaching efficiency 87% under the same condition. We calculated cell death distribution in depth direction based on measured photocytotoxicity under various pulse energy densities. The possibility of depth controlled PDT for safety atheromatous plaque therapy was suggested by the PDT effect alteration depending on pulse energy density.

Original languageEnglish
Title of host publicationProceedings of SPIE - The International Society for Optical Engineering
EditorsS.L. Jacques, W.P. Roach
Pages96-100
Number of pages5
Volume5319
DOIs
Publication statusPublished - 2004
EventProgress in Biomedical Optics and Imaging - Laser Interaction with Tissue and Cells XV - San Jose, CA, United States
Duration: 2004 Jan 262004 Jan 28

Other

OtherProgress in Biomedical Optics and Imaging - Laser Interaction with Tissue and Cells XV
CountryUnited States
CitySan Jose, CA
Period04/1/2604/1/28

Fingerprint

Photodynamic therapy
Dosimetry
dosimeters
therapy
flux density
Photobleaching
Photosensitizers
pulses
Oxygen
Partial pressure
Laser pulses
partial pressure
repetition
oxygen
Pulse repetition rate
Laser excitation
Dye lasers
Lasers
Macrophages
excitation

Keywords

  • Atheromatous plaque
  • Depth control
  • Macrophage targetting
  • Photodynamic therapy
  • Second-generation water-soluble photosensitizer

ASJC Scopus subject areas

  • Electrical and Electronic Engineering
  • Condensed Matter Physics

Cite this

Ohmori, S., Yanagihara, T., & Arai, T. (2004). Direct photodynamic therapy for vulnerable plaque: Investigation of light dosimetry for depth control. In S. L. Jacques, & W. P. Roach (Eds.), Proceedings of SPIE - The International Society for Optical Engineering (Vol. 5319, pp. 96-100) https://doi.org/10.1117/12.528993

Direct photodynamic therapy for vulnerable plaque : Investigation of light dosimetry for depth control. / Ohmori, S.; Yanagihara, T.; Arai, Tsunenori.

Proceedings of SPIE - The International Society for Optical Engineering. ed. / S.L. Jacques; W.P. Roach. Vol. 5319 2004. p. 96-100.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ohmori, S, Yanagihara, T & Arai, T 2004, Direct photodynamic therapy for vulnerable plaque: Investigation of light dosimetry for depth control. in SL Jacques & WP Roach (eds), Proceedings of SPIE - The International Society for Optical Engineering. vol. 5319, pp. 96-100, Progress in Biomedical Optics and Imaging - Laser Interaction with Tissue and Cells XV, San Jose, CA, United States, 04/1/26. https://doi.org/10.1117/12.528993
Ohmori S, Yanagihara T, Arai T. Direct photodynamic therapy for vulnerable plaque: Investigation of light dosimetry for depth control. In Jacques SL, Roach WP, editors, Proceedings of SPIE - The International Society for Optical Engineering. Vol. 5319. 2004. p. 96-100 https://doi.org/10.1117/12.528993
Ohmori, S. ; Yanagihara, T. ; Arai, Tsunenori. / Direct photodynamic therapy for vulnerable plaque : Investigation of light dosimetry for depth control. Proceedings of SPIE - The International Society for Optical Engineering. editor / S.L. Jacques ; W.P. Roach. Vol. 5319 2004. pp. 96-100
@inproceedings{92fcd61883314bf88662975ca1a8f183,
title = "Direct photodynamic therapy for vulnerable plaque: Investigation of light dosimetry for depth control",
abstract = "Photodynamic therapy (PDT) mechanism with high-intensity pulsed laser excitation has not been well understood. We think complete understanding of this unknown effect in PDT leads perfect treated depth control at various lesions. To realize the depth controlled PDT for atheromatous plaque therapy with a fibrous cap intact and surrounding damage free, we studied PDT against murine macrophage-like cells in vitro with the second-generation chlorin photosensitizer manufactured by Photochemical Co. Ltd. (Okayama Japan). The relation between the excitation conditions (pulse energy density and repetition rate) and PDT photocytotoxicity was examined in vitro. The XeCl excimer laser pumped dye laser (wavelength: 669±3 nm, pulse duration: 7ns in FWHM) was used with the pulse energy density from 1.2 to 9.5 mJ/cm2, and the pulse repetition rate from 5 to 80 Hz. Under higher pulse energy density condition, no significant PDT photocytotoxicity was obtained. We examined the photobleaching of the protein containing photosensitizer medium solution, which is considered to correlates with the generation of singlet oxygen. Under higher pulse energy condition, the photobleaching efficiency decrease was observed and the measured PDT effect decrease in terms of laser pulse energy density could be explained by the photobleaching. We measured the oxygen partial pressure in photosensitizer medium solution immediately after the laser exposure. The decrease of oxygen partial pressure, i.e., the amount of the oxygen consumption during the laser exposure was observed 46 mmHg under the excitation condition of the pulse energy density of 9.5 mJ/cm2, the total fluence of 5 J/cm2, the repetition rate of 80Hz, and correlated with the bleaching efficiency 87{\%} under the same condition. We calculated cell death distribution in depth direction based on measured photocytotoxicity under various pulse energy densities. The possibility of depth controlled PDT for safety atheromatous plaque therapy was suggested by the PDT effect alteration depending on pulse energy density.",
keywords = "Atheromatous plaque, Depth control, Macrophage targetting, Photodynamic therapy, Second-generation water-soluble photosensitizer",
author = "S. Ohmori and T. Yanagihara and Tsunenori Arai",
year = "2004",
doi = "10.1117/12.528993",
language = "English",
volume = "5319",
pages = "96--100",
editor = "S.L. Jacques and W.P. Roach",
booktitle = "Proceedings of SPIE - The International Society for Optical Engineering",

}

TY - GEN

T1 - Direct photodynamic therapy for vulnerable plaque

T2 - Investigation of light dosimetry for depth control

AU - Ohmori, S.

AU - Yanagihara, T.

AU - Arai, Tsunenori

PY - 2004

Y1 - 2004

N2 - Photodynamic therapy (PDT) mechanism with high-intensity pulsed laser excitation has not been well understood. We think complete understanding of this unknown effect in PDT leads perfect treated depth control at various lesions. To realize the depth controlled PDT for atheromatous plaque therapy with a fibrous cap intact and surrounding damage free, we studied PDT against murine macrophage-like cells in vitro with the second-generation chlorin photosensitizer manufactured by Photochemical Co. Ltd. (Okayama Japan). The relation between the excitation conditions (pulse energy density and repetition rate) and PDT photocytotoxicity was examined in vitro. The XeCl excimer laser pumped dye laser (wavelength: 669±3 nm, pulse duration: 7ns in FWHM) was used with the pulse energy density from 1.2 to 9.5 mJ/cm2, and the pulse repetition rate from 5 to 80 Hz. Under higher pulse energy density condition, no significant PDT photocytotoxicity was obtained. We examined the photobleaching of the protein containing photosensitizer medium solution, which is considered to correlates with the generation of singlet oxygen. Under higher pulse energy condition, the photobleaching efficiency decrease was observed and the measured PDT effect decrease in terms of laser pulse energy density could be explained by the photobleaching. We measured the oxygen partial pressure in photosensitizer medium solution immediately after the laser exposure. The decrease of oxygen partial pressure, i.e., the amount of the oxygen consumption during the laser exposure was observed 46 mmHg under the excitation condition of the pulse energy density of 9.5 mJ/cm2, the total fluence of 5 J/cm2, the repetition rate of 80Hz, and correlated with the bleaching efficiency 87% under the same condition. We calculated cell death distribution in depth direction based on measured photocytotoxicity under various pulse energy densities. The possibility of depth controlled PDT for safety atheromatous plaque therapy was suggested by the PDT effect alteration depending on pulse energy density.

AB - Photodynamic therapy (PDT) mechanism with high-intensity pulsed laser excitation has not been well understood. We think complete understanding of this unknown effect in PDT leads perfect treated depth control at various lesions. To realize the depth controlled PDT for atheromatous plaque therapy with a fibrous cap intact and surrounding damage free, we studied PDT against murine macrophage-like cells in vitro with the second-generation chlorin photosensitizer manufactured by Photochemical Co. Ltd. (Okayama Japan). The relation between the excitation conditions (pulse energy density and repetition rate) and PDT photocytotoxicity was examined in vitro. The XeCl excimer laser pumped dye laser (wavelength: 669±3 nm, pulse duration: 7ns in FWHM) was used with the pulse energy density from 1.2 to 9.5 mJ/cm2, and the pulse repetition rate from 5 to 80 Hz. Under higher pulse energy density condition, no significant PDT photocytotoxicity was obtained. We examined the photobleaching of the protein containing photosensitizer medium solution, which is considered to correlates with the generation of singlet oxygen. Under higher pulse energy condition, the photobleaching efficiency decrease was observed and the measured PDT effect decrease in terms of laser pulse energy density could be explained by the photobleaching. We measured the oxygen partial pressure in photosensitizer medium solution immediately after the laser exposure. The decrease of oxygen partial pressure, i.e., the amount of the oxygen consumption during the laser exposure was observed 46 mmHg under the excitation condition of the pulse energy density of 9.5 mJ/cm2, the total fluence of 5 J/cm2, the repetition rate of 80Hz, and correlated with the bleaching efficiency 87% under the same condition. We calculated cell death distribution in depth direction based on measured photocytotoxicity under various pulse energy densities. The possibility of depth controlled PDT for safety atheromatous plaque therapy was suggested by the PDT effect alteration depending on pulse energy density.

KW - Atheromatous plaque

KW - Depth control

KW - Macrophage targetting

KW - Photodynamic therapy

KW - Second-generation water-soluble photosensitizer

UR - http://www.scopus.com/inward/record.url?scp=5644228825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644228825&partnerID=8YFLogxK

U2 - 10.1117/12.528993

DO - 10.1117/12.528993

M3 - Conference contribution

AN - SCOPUS:5644228825

VL - 5319

SP - 96

EP - 100

BT - Proceedings of SPIE - The International Society for Optical Engineering

A2 - Jacques, S.L.

A2 - Roach, W.P.

ER -